Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer -
IF Tannock, R de Wit, WR Berry, J Horti, A … - New England Journal of Medicine, 2004 - content.nejm.org
... 10: 18-22 [Abstract] [Full Text]; Berry, W., Eisenberger, M. (2005). Achieving
Treatment Goals for Hormone-Refractory Prostate Cancer with Chemotherapy. ...
… and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer -
… Jones, ME Taplin, PA Burch, D Berry, C Moinpour, M … - New England Journal of Medicine, 2004 - content.nejm.org
... 10: 18-22 [Abstract] [Full Text]; Berry, W., Eisenberger, M. (2005). Achieving
Treatment Goals for Hormone-Refractory Prostate Cancer with Chemotherapy. ...
c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer -
HB Muss, AD Thor, DA Berry, T Kute, ET Liu, F … - New England Journal of Medicine, 1994 - content.nejm.org
... BW, Atkins, CD, Wood, WC, Budman, D., Henderson, IC, Muss, HB, Thor, AD, Berry,
DA, Goldhirsch, A., Gelber, RD (1994). Adjuvant Therapy for Breast Cancer. ...
… Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer -
IC Henderson, DA Berry, GD Demetri, CT Cirrincione … - Journal of Clinical Oncology, 2003 - jco.ascopubs.org
... Text]; Budman DR, Berry DA, Cirrincione CT, et al: Dose and dose intensity as
determinants of outcome in the adjuvant treatment of breast cancer: The Cancer and ...
… ) dose level in the adjuvant chemotherapy of patients (PTS) with node-positive primary breast cancer … -
IC Henderson, D Berry, G Demetri, C Cirrincione, L … - Proc Am Soc Clin Oncol, 1998 - asco.org
... Patients. (Meeting abstract). Meeting: 1999 ASCO Annual Meeting Abstract No:
490 First Author: Berry Donald Category: Breast Cancer. 2. ...
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer -
… , P Ashley, LW Bassett, D Berry, KI Bland, PI … - Journal of Clinical Oncology, 2002 - jcojournal.org
... Joint Committee on Cancer Staging System for Breast Cancer. By S. Eva Singletary ,
Craig Allred , Pandora Ashley , Lawrence W. Bassett , Donald Berry , Kirby I ...
Evidence for a prostate cancer susceptibility locus on the X chromosome. -
… T Visakorpi, OP Kallioniemi, R Berry, D Schaid, A … - Nature Genetics, 1998 - nature.com
... Evidence for a prostate cancer susceptibility locus on the X chromosome. ... Tammela
5 , Tapio Visakorpi 5 , Olli-P. Kallioniemi 12 , Rebecca Berry * 6 , Daniel ...
Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history -
DA Berry - J Natl Cancer I, 1997 - jnci.oxfordjournals.org
... Home page, JNCI J Natl Cancer Inst Home page DA Berry Role of Population-Based Studies
in Assessing Genetic Cancer Risk J Natl Cancer Inst, August 15, 2001; 93 ...
Determining Carrier Probabilities for Breast Cancer-Susceptibility Genes BRCA1 and BRCA2 -
G Parmigiani, DA Berry, O Aguilar - The American Journal of Human Genetics, 1998 - UChicago Press
... Berry DA, Parmigiani G, Sanchez J, Schildkraut JM, Winer E (1997) Assessing the
probability of carrying a breast cancer gene BRCA1 based on family history. ...
… of a Randomized Trial in Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer -
… , AA Sahin, MS Ewer, TA Buchholz, D Berry, GN … - Journal of Clinical Oncology, 2005 - jco.ascopubs.org
... 45:1197-1211, 1989[CrossRef][Medline]; Berry DA: Statistical innovations in cancer
research, in Holland J, Frei T, Kufe DW, et al (eds): Cancer Medicine. ...
Source: Google Scholar |